RA
GMED icon

Rise Advisors’s Globus Medical GMED Stock Holding History

Rise Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-240
Closed -$13.7K – 645
2025
Q3 		$13.7K Hold
240
– – ﹤0.01% 812
2025
Q2 		$14.2K Hold
240
– – 0.01% 775
2025
Q1 		$17.6K Sell
240
-59
-20% -$4.88K 0.01% 583
2024
Q4 		$24.7K Sell
299
-75
-20% -$5.92K 0.01% 512
2024
Q3 		$26.8K Hold
374
– – 0.01% 476
2024
Q2 		$25.6K Hold
374
– – 0.01% 462
2024
Q1 		$20.1K Buy
374
+299
+399% +$16.1K 0.01% 648
2023
Q4 		$4K Hold
75
– – ﹤0.01% 396
2023
Q3 		$3.72K Hold
75
– – ﹤0.01% 404
2023
Q2 		$4.47K Sell
75
-46
-38% -$2.62K ﹤0.01% 430
2023
Q1 		$6.85K Hold
121
– – 0.01% 413
2022
Q4 		$8.99K Hold
121
– – 0.01% 364
2022
Q3 		$7K Hold
121
– – 0.01% 388
2022
Q2 		$7K Hold
121
– – 0.01% 393
2022
Q1 		$9K Buy
121
+20
+20% +$1.39K 0.01% 343
2021
Q4 		$7.29K Buy
+101
New +$7.33K 0.01% 361

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Rise Advisors's GMED Position: Q4 2025 in Review

Rise Advisors sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 240 shares — an estimated $13.7K sold.

Rise Advisors first reported a position in GMED in Q4 2021 and held it in 16 quarters. The position peaked at $26.8K in Q3 2024. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Rise Advisors reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 240 Globus Medical shares in Q4 2025, an estimated $13.7K.
  • Rise Advisors first reported a position in Globus Medical in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Globus Medical position peaked at $26.8K in Q3 2024.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.